25.50
Privia Health Group Inc stock is traded at $25.50, with a volume of 909.80K.
It is up +2.12% in the last 24 hours and up +4.04% over the past month.
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
See More
Previous Close:
$24.97
Open:
$25.26
24h Volume:
909.80K
Relative Volume:
0.83
Market Cap:
$3.21B
Revenue:
$2.25B
Net Income/Loss:
$27.39M
P/E Ratio:
151.97
EPS:
0.1678
Net Cash Flow:
$136.77M
1W Performance:
-5.20%
1M Performance:
+4.04%
6M Performance:
+6.52%
1Y Performance:
+29.44%
Privia Health Group Inc Stock (PRVA) Company Profile
Name
Privia Health Group Inc
Sector
Industry
Phone
571-366-8850
Address
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA vs VEEV, BTSG, HQY, TEM, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PRVA
Privia Health Group Inc
|
25.50 | 3.21B | 2.25B | 27.39M | 136.77M | 0.1678 |
|
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-16-24 | Initiated | Macquarie | Outperform |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Feb-22-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-23 | Initiated | Evercore ISI | Outperform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Mar-10-23 | Initiated | RBC Capital Mkts | Outperform |
| Feb-03-23 | Initiated | Goldman | Buy |
| Dec-09-22 | Initiated | Stifel | Buy |
| Dec-08-22 | Initiated | UBS | Buy |
| Sep-07-22 | Resumed | Truist | Buy |
| May-03-22 | Initiated | BofA Securities | Buy |
| Apr-28-22 | Initiated | BTIG Research | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Feb-22-22 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-03-22 | Initiated | Jefferies | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| May-24-21 | Initiated | Canaccord Genuity | Buy |
| May-24-21 | Initiated | Credit Suisse | Outperform |
| May-24-21 | Initiated | JP Morgan | Overweight |
| May-24-21 | Initiated | Piper Sandler | Overweight |
| May-24-21 | Initiated | Truist | Buy |
| May-24-21 | Initiated | William Blair | Outperform |
View All
Privia Health Group Inc Stock (PRVA) Latest News
Privia Health Group Inc (PRVA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Privia Health stock rebounded from lows to $25.50 as support holds above medium-term averages - Traders Union
3 Reasons to Avoid PRVA and 1 Stock to Buy Instead - Yahoo! Finance Canada
Citi Maintains Privia Health(PRVA.US) With Buy Rating, Raises Target Price to $35 - Moomoo
Privia Health Group Inc (PRVA) Shares Fall 3.6% -- What GF Score of 88 Tells Investors - GuruFocus
(PRVA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Privia Health Group (PRVA) Declines 1.18% as Stock Nears Key Support at $25.55Insider Selling Alerts - dars.gov.et
Top 3 Health Care Stocks That May Implode This Month - Benzinga
Privia Health Group, Inc. (PRVA) Stock Forecasts - Yahoo Finance
Price to book forward of Privia Health Group, Inc. – NASDAQ:PRVA - TradingView
Privia Health Group Insider Sold Shares Worth $588,679, According to a Recent SEC Filing - Moomoo
Privia Health (PRVA) CFO Mountcastle sells 21,275 shares under 10b5-1 plan - Stock Titan
What Does a Privia Health Insider's Sale of Company Shares for $3.6 Million Mean for Investors? - AOL.com
RBC Capital Keeps Their Buy Rating on Privia Health Group (PRVA) - The Globe and Mail
Privia Health Group stock hits 52-week high at $27.71 By Investing.com - Investing.com India
Form 144 Privia Health Group For: 9 July By Investing.com - Investing.com South Africa
Form 4 Privia Health Group Inc For: 9 July By Investing.com - Investing.com Nigeria
Privia Health CFO Mountcastle sells $16,542 in company stock By Investing.com - Investing.com Australia
David Mountcastle sells multiple PRVA shares (PRVA) including 24,734 on 07/02/2026 - Stock Titan
Privia Health CFO Mountcastle sells $16,542 in company stock - Investing.com UK
Privia Health (PRVA) CFO sells 600 shares, keeps over 186K stake - Stock Titan
Privia Health Group stock hits 52-week high at $27.71 - Investing.com
Privia Health Group (PRVA) Holds Steady Amid Sector Shifts – Key Levels in FocusFundamental Weighted - dars.gov.et
RBC Capital Maintains Privia Health(PRVA.US) With Buy Rating, Maintains Target Price $31 - Moomoo
Form 144 Privia Health Group For: 7 July By Investing.com - Investing.com South Africa
Form 4 Privia Health Group Inc For: 7 July By Investing.com - Investing.com Nigeria
Privia Health Group EVP & CFO David Mountcastle sells $680k in shares - Investing.com
Shawn Morris resigns from Privia Health Group board and compliance committee - TradingView
Board member Shawn Morris exits Privia Health (NASDAQ: PRVA) role - Stock Titan
Privia Health Group (PRVA) director reports 112,759-share option exercise and sale - Stock Titan
Privia Health Group (PRVA) CFO sells 24,734 shares in planned trade - Stock Titan
PRVA (NASDAQ: PRVA) Form 144: 600 vested shares; insider sold 24,734 on 07/02/2026 - Stock Titan
Privia Health to report Q2 2026 results on August 6 - scanx.trade
PRVA Q1 2026 Earnings: EPS Misses Estimates by Wide Margin; Shares Edge LowerPerformance Review - dars.gov.et
Privia Health to Report Second Quarter 2026 Results on Thursday, August 6 - The Manila Times
Privia Health sets Aug. 6 earnings call and outlook update - Stock Titan
Press Release: Privia Health to Report Second Quarter 2026 Results on Thursday, August 6 - Moomoo
Privia Health Q1 2026 slides show operational strength, earnings disappoint - Investing.com
Privia Health stock rises 1.79 percent to $27.36 as PriviaHealth shares upbeat Independence Day message - Traders Union
3 Quality Stocks Built For A Pricey Market - Sahm
Form 144 Privia Health Group For: 2 July By Investing.com - Investing.com Nigeria
PRVA (NASDAQ: PRVA) insider sales reported, with restricted stock vesting noted - Stock Titan
Director at Privia Health (PRVA) sells 135,498 shares after option exercise - Stock Titan
Is It Too Late to Buy Privia Health Group Inc (PRVA) After 4.5% Rally? GF Value Says Undervalued - GuruFocus
Privia Health Group stock hits 52-week high at 26.53 USD - Investing.com
Privia Health Group Inc Stock (PRVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):